Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTR7 | P34969 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5724883 | 0.92 | RAB9A (0.68) | RAB9ANPC1PTPN1L3MBTL1LMNA | |
| SCHEMBL7167952 | 0.92 | SRD5A2 (0.62) | RAB9ANPC1PTPN1L3MBTL1LMNA | |
| SCHEMBL6203410 | 0.90 | PTPN1 (0.55) | RAB9ANPC1PTPN1LMNAHTT | |
| SCHEMBL31151831 | 0.90 | NPC1 (0.69) | RAB9ANPC1PTPN1L3MBTL1LMNA | |
| SCHEMBL21180477 | 0.90 | RAB9A (0.50) | RAB9ANPC1PTPN1L3MBTL1LMNA | |
| SCHEMBL8956384 | 0.90 | RAB9A (0.71) | RAB9ANPC1PTPN1L3MBTL1MAPT | |
| SCHEMBL6202445 | 0.90 | RAB9A (0.71) | RAB9ANPC1PTPN1L3MBTL1MAPT | |
| SCHEMBL6199282 | 0.90 | PTPN1 (0.55) | RAB9ANPC1PTPN1LMNAHTT | |
| SCHEMBL682591 | 0.90 | L3MBTL1 (0.67) | RAB9ANPC1PTPN1L3MBTL1LMNA | |
| SCHEMBL71493 | 0.90 | L3MBTL1 (0.56) | RAB9ANPC1L3MBTL1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054902-A | Metal halide perovskite film, preparation method thereof and photovoltaic device | 南京工业大学 | 2026-05-15 | — | — | CN | claimed |
| US-6040484-A | HYDROXYLATION OF PHENOLIC COMPOUNDS USING HYDROGEN PEROXIDE AND A CATALYST OF AT LEAST ONE RARE EARTH OR BISMUTH TRIFLATE; CATALYST SELECTIVITY | RHODIA CHIMIE (FR) | 2000-03-21 | — | — | US | claimed |
| US-5331103-A | Reaction with hydrogen peroxide, hydroquinone from phenol | RHONE-POULENC CHIMIE (FR) | 1994-07-19 | — | — | US | claimed |
| CN-122054902-A | Metal halide perovskite film, preparation method thereof and photovoltaic device | 南京工业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |
| US-9653692-B2 | Light-emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9469645-B2 | Compounds and compositions for the treatment of parasitic diseases | NOVARTIS AG (CH) | 2016-10-18 | — | — | US | disclosed |
| US-9469645-B2 | Compounds and compositions for the treatment of parasitic diseases | NOVARTIS AG (CH) | 2016-10-18 | — | — | US | disclosed |
| US-9370522-B2 | Heterocyclic compounds for the inhibition of PASK | BIOENERGENIX, LLC (US) | 2016-06-21 | — | — | US | disclosed |
| US-9370522-B2 | Heterocyclic compounds for the inhibition of PASK | BIOENERGENIX, LLC (US) | 2016-06-21 | — | — | US | disclosed |
| US-5543573-A | INSECTICIDES | NIHON NOHYAKU CO., LTD. (JP) | 1996-08-06 | — | — | US | disclosed |
| EP-0462456-B1 | Hydrazinecarboxamide derivatives, a process for production thereof, and uses thereof | NIHON NOHYAKU CO LTD (JP) | 1996-05-08 | — | — | EP | disclosed |
| EP-0388081-B1 | Agent for the treatment of disorders of the cerebral neurotransmitter system | SANTEN PHARMACEUTICAL CO LTD (JP) | 1995-12-27 | — | — | EP | disclosed |
| EP-0231622-B1 | Inhibition of the 5-lipoxygenase pathway | SMITHKLINE BEECHAM CORP (US) | 1994-08-24 | — | — | EP | disclosed |
| US-5331103-A | Reaction with hydrogen peroxide, hydroquinone from phenol | RHONE-POULENC CHIMIE (FR) | 1994-07-19 | — | — | US | disclosed |
| US-5153198-A | Fluoro-diphenylethylpiperazine for treating nervous system and brain disorders | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | disclosed |
| US-5087627-A | Administering diphenylethylpiperazine derivatives | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1992-02-11 | — | — | US | disclosed |
| EP-0462456-A1 | Hydrazinecarboxamide derivatives, a process for production thereof, and uses thereof | NIHON NOHYAKU CO., LTD. (JP) | 1991-12-27 | — | — | EP | disclosed |
| EP-0388081-A2 | Agent for the treatment of disorders of the cerebral neurotransmitter system | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |